![Lisa M Campbell Regulatory Analyst Bergeson Campbell law firm](/sites/default/files/styles/author_profile/public/2023-12/12_29_23%20Carla%20Hutton.jpg?h=506c123e&itok=Utzt7Gy1)
Since 1996, Carla Hutton has monitored, researched, and written about regulatory and legislative issues that may potentially affect Bergeson & Campbell, P.C. (B&C®) clients. She is responsible for creating a number of monthly and quarterly regulatory updates for B&C's clients, as well as other documents, such as chemical-specific global assessments of regulatory developments and trends. She authors memoranda for B&C clients on regulatory and legislative developments, providing information that is focused, timely and applicable to client initiatives. These tasks have proven invaluable to many clients, keeping them aware and abreast of developing issues so that they can respond in kind and prepare for the future of their business.
Ms. Hutton brings a wealth of experience and judgment to her work in federal, state, and international chemical regulatory and legislative issues, including green chemistry, nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the Toxic Substances Control Act (TSCA), Proposition 65, and the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) program.
Carla Hutton's strengths include the ability to provide quickly and efficiently timely, relevant, and accurate information on specific issues for clients. Through daily monitoring of regulatory news, EPA information and other resources, she stays on top of government agency and legislative developments as they occur and quickly prepares notifications on various issues. Ms. Hutton has authored several assessments for client-specific materials. Prepared under tight deadlines, these documents still provide detailed analysis of state, federal, and international regulatory trends and developments.
Representative Engagements:
- Writes a metal-specific quarterly regulatory update for an international association of producers, users, and traders.
- Prepares and writes a quarterly update focused on chemical management regulations in Asia for metals industry associations.
- Authors items for the Nano and Other Emerging Chemical Technologies Blog, which reports on federal, local, and international regulatory, legal, and policy developments and is utilized by clients in nanotechnologies and other chemical technologies.
- Prepares a chemical-specific global assessment of regulatory developments and trends, analyzing the triggers initiating the regulatory initiatives, including scientific developments and regulatory actions undertaken in response by environmental activists, public health activists, and related stakeholders, as well as other complicating factors.
More Legal and Business Bylines From Carla N. Hutton
- EPA Publishes Interim Guidance on Destroying and Disposing of Certain PFAS and PFAS-Containing Materials - (Posted On Wednesday, December 23, 2020)
- OECD Publishes Reports on Outcome of Project on Advancing Adverse Outcome Pathway Development for Nanomaterial Risk Assessment and Categorization - (Posted On Tuesday, December 22, 2020)
- EPA Releases Proposed Amendments to TSCA Fees Rule - (Posted On Tuesday, December 22, 2020)
- Comments on Draft Compliance Guide Addressing Surface Coatings under PFAS SNUR Due January 15 - (Posted On Monday, December 21, 2020)
- EPA Releases Final Risk Evaluation for Perchloroethylene, Finds Almost All Conditions of Use Present Unreasonable Risks to Workers, ONUs, Consumers, and Bystanders - (Posted On Tuesday, December 15, 2020)
- EPA Seeks Participants for Small Business Review Panel on Carbon Tetrachloride and TCE Risk Management Rulemaking - (Posted On Friday, December 11, 2020)
- EUON Conducting Web Satisfaction Survey - (Posted On Friday, December 11, 2020)
- ANSES Evaluates R-Nano Register, Offers Recommendations to Improve Reliability and Optimize Its Use - (Posted On Wednesday, December 09, 2020)
- December 3 Workshop Will Discuss Creating a NanoRisk Governance Council - (Posted On Tuesday, December 01, 2020)
- EUON Publishes Results of Study on What EU Citizens Think about Nanomaterials - (Posted On Monday, November 30, 2020)
The National Law Review recognizes Carla N. Hutton a Regulatory Analyst at Bergeson and Campbell as a Go-To Thought Leader for her consistent coverage of EPA rulemaking and stakeholder commentary opportunities, developments involving the (NNI) U.S. National Nanotechnology Initiative and regulatory changes concerning the European Commission (EC) Scientific Committee on Consumer Safety (SCCS). For more than two decades, Ms. Hutton has monitored, researched, and analyzed federal, state, and international chemical regulatory and legislative issues and her depth of knowledge provides NLR readers with updates that are focused, timely and digestible for a business audience. Ms. Hutton along with other professionals at Bergeson & Campbell provide updates several times a week on a wide range of matters involving the Toxic Substances Control Act (TSCA), nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and newly introduced legislation on low carbon fuel production.
Bergeson & Campbell is a Go-To Thought Leader for 2021 for its reporting on the Toxic Substances Control Act (TSCA) and Per- and Polyfluoroalkyl Substances (PFAS). Readers turn to the firm’s expert insights on the EPA's regulation and new rulemaking. Managing Partner Lynn L. Bergeson and Regulatory Analyst Carla N. Hutton alongside other professionals from Bergeson & Campbell provide readers with essential guidance they need to comply with these ever-changing government regulations.
The National Law Review names Bergeson & Campbell a Go-To Thought Leader in the field of Biotech, Food, and Drug law. Authors Lynn L. Bergeson and Carla N. Hutton covered extensively the White House’s new biotechnology initiative in their September 2022 article, “President Biden Launches National Biotechnology and Biomanufacturing Initiative.” The coverage reached thousands of legal and industry leaders and remains a valuable resource on the federal government’s new biotechnology focus.